Todd and his family have a history of enjoying music and many outdoor activities together. So at only 42 years old, Todd never expected he'd be diagnosed with advanced prostate cancer. With four children, five grandchildren, and a new wife, he decided to work vigilantly with his physicians to come up with a treatment plan that included PROVENGE® (sipulelcel-T). After initial treatments stopped working and his cancer progressed, Todd received PROVENGE in mid-2012. Todd truly values the experiences he shares with his family with every new day.
Tim is a fifth-grade teacher with three children and two grandchildren. He has always been on the move, whether teaching, or enjoying outdoor activities with his family. Tim never thought he'd be battling prostate cancer at 52 years old. After the initial shock of diagnosis, he had to take action against prostate cancer. When his cancer spread after two years of treatment, his doctor recommended PROVENGE® (sipuleucel-T), which he received in early 2012. Tim's fifth-grade students still keep him busy, and he is still focused on family activities.
PROVENGE® (sipuleucel-T) is the first and only FDA-approved immunotherapy for advanced prostate cancer. PROVENGE takes the body’s own immune cells and reprograms them to attack advanced prostate cancer.
PROVENGE® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information.